Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 19Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Follicular 12Lymphoma, Non-Hodgkin 11Lymphoma, Mantle-Cell 8Lymphoma, B-Cell, Marginal Zone 6Leukemia, Lymphocytic, Chronic, B-Cell 6Waldenstrom Macroglobulinemia 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 3Burkitt Lymphoma 3Lymphoma, B-Cell 2Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Orbital lymphoma 1Oncology Patients Receiving Chemotherapy 1Neoplasms by Histologic Type 1Neoplasms 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Immunoproliferative Disorders 1Immune System Diseases 1Graft vs Host Disease 1

Interventions

ibritumomab tiuxetan 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Orbital lymphoma × ibritumomab tiuxetan × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡